FSR Wealth Management Ltd. Makes New $238,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

FSR Wealth Management Ltd. purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 400 shares of the biotechnology company’s stock, valued at approximately $238,000.

Several other institutional investors and hedge funds have also modified their holdings of AXON. Comprehensive Financial Planning Inc. PA bought a new position in Axon Enterprise in the 4th quarter valued at approximately $150,000. Savant Capital LLC lifted its stake in shares of Axon Enterprise by 5.7% in the 4th quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company’s stock valued at $642,000 after acquiring an additional 58 shares during the last quarter. Burns Matteson Capital Management LLC grew its position in Axon Enterprise by 3.4% during the 4th quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock worth $450,000 after acquiring an additional 25 shares during the last quarter. Kestra Private Wealth Services LLC increased its holdings in Axon Enterprise by 44.6% in the 4th quarter. Kestra Private Wealth Services LLC now owns 14,420 shares of the biotechnology company’s stock worth $8,570,000 after purchasing an additional 4,449 shares in the last quarter. Finally, Entropy Technologies LP bought a new position in Axon Enterprise in the fourth quarter valued at about $2,250,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

AXON opened at $679.24 on Monday. Axon Enterprise, Inc. has a 1-year low of $255.68 and a 1-year high of $698.67. The company has a market cap of $51.79 billion, a price-to-earnings ratio of 175.51, a PEG ratio of 6.79 and a beta of 1.05. The company’s fifty day moving average price is $623.43 and its two-hundred day moving average price is $496.32. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analysts Set New Price Targets

AXON has been the topic of several research reports. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $542.15.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last quarter. Insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.